Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1378 record(s)

Req # A-2021-000746

Adverse Drug Reactions (ADRs) for. Report numbers: E2B_03830553, E2B_04005470, E2B_04005482, E2B_04010997, E2B_04015182, E2B_04017190, E2B_04029801, E2B_04077964, E2B_04086479, E2B_04088871, 000940326, E2B_03857154, E2B_03965590, E2B_03968250, E2B_03990216, E2B_03992837, E2B_03994182, E2B_04017773, E2B_04029600, E2B_04071220.

Organization: Health Canada

437 page(s)
December 2021

Req # A-2021-000757

Adverse Drug Reaction (ADR). Report number: E2B_03995825.

Organization: Health Canada

13 page(s)
December 2021

Req # A-2021-000794

Adverse Drug Reactions (ADRs) for AMITRIPTYLINE HYDROCHLORIDE. Report numbers: 000926354, E2B_03334949.

Organization: Health Canada

38 page(s)
December 2021

Req # A-2021-000806

Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03339245, E2B_03510889.

Organization: Health Canada

44 page(s)
December 2021

Req # A-2021-000812

Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03501636, E2B_03500488, E2B_03484433, E2B_03452355, E2B_03477502, E2B_03478053, E2B_03482536, E2B_03278615, E2B_03324820, E2B_03380092, E2B_03285246, E2B_03400891, E2B_03410468, E2B_03406006, E2B_03413948.

Organization: Health Canada

406 page(s)
December 2021

Req # A-2021-000813

Adverse Drug Reactions (ADRs) for IPRATROPIUM BROMIDE. Report numbers: E2B_03434660, E2B_03473185.

Organization: Health Canada

49 page(s)
December 2021

Req # A-2021-000827

Adverse Drug Reaction (ADR) for TRANDOLAPRIL. Report number: E2B_03480899.

Organization: Health Canada

25 page(s)
December 2021

Req # A-2021-000835

Adverse Drug Reaction (ADR) for SULFASALAZINE. Report number: E2B_03278682.

Organization: Health Canada

26 page(s)
December 2021

Req # A-2021-000836

Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: E2B_03478043, 000926738, 000927160, E2B_03408952, E2B_03424958, E2B_03428714, E2B_03481171, E2B_03453800, E2B_03456738, E2B_03452292, E2B_03448466.

Organization: Health Canada

242 page(s)
December 2021

Req # A-2021-000844

Adverse Drug Reactions (ADRs) for PETHIDINE HYDROCHLORIDE. Report numbers: E2B_03497961, E2B_03491971, E2B_03304369, E2B_03282744, E2B_03326776.

Organization: Health Canada

162 page(s)
December 2021
Date modified: